- Home
- SNES vs TNON Comparison
SNES vs TNON Comparison
Compare SNES & TNON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- TNON
- Stock Information
- Founded
- SNES 2004
- TNON 2012
- Country
- SNES United States
- TNON United States
- Employees
- SNES N/A
- TNON N/A
- Industry
- SNES Agricultural Chemicals
- TNON Medical Specialities
- Sector
- SNES Industrials
- TNON Health Care
- Exchange
- SNES Nasdaq
- TNON Nasdaq
- Market Cap
- SNES 2.3M
- TNON 2.2M
- IPO Year
- SNES 2016
- TNON 2022
- Fundamental
- Price
- SNES $3.16
- TNON $1.85
- Analyst Decision
- SNES Strong Buy
- TNON Strong Buy
- Analyst Count
- SNES 1
- TNON 2
- Target Price
- SNES $10.00
- TNON $16.00
- AVG Volume (30 Days)
- SNES 311.7K
- TNON 147.3K
- Earning Date
- SNES 11-12-2024
- TNON 11-13-2024
- Dividend Yield
- SNES N/A
- TNON N/A
- EPS Growth
- SNES N/A
- TNON N/A
- EPS
- SNES N/A
- TNON N/A
- Revenue
- SNES $1,651,000.00
- TNON $3,315,000.00
- Revenue This Year
- SNES $91.45
- TNON $29.03
- Revenue Next Year
- SNES $101.31
- TNON $100.29
- P/E Ratio
- SNES N/A
- TNON N/A
- Revenue Growth
- SNES 38.16
- TNON 38.30
- 52 Week Low
- SNES $1.90
- TNON $1.82
- 52 Week High
- SNES $21.40
- TNON $17.19
- Technical
- Relative Strength Index (RSI)
- SNES 56.47
- TNON 22.38
- Support Level
- SNES $2.32
- TNON $1.82
- Resistance Level
- SNES $5.00
- TNON $2.30
- Average True Range (ATR)
- SNES 0.52
- TNON 0.13
- MACD
- SNES 0.13
- TNON 0.01
- Stochastic Oscillator
- SNES 35.66
- TNON 5.88
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About TNON Tenon Medical Inc.
Tenon Medical Inc is a medical device company that has developed a novel, minimally invasive approach to the sacroiliac joint (the SI Joint) using a single, robust, titanium implant for the treatment of the common types of SI Joint disorders that cause lower back pain. The Company is focused on three commercial opportunities: 1) Primary SI Joint procedures, 2) Revision procedures of failed SI Joint implants, and 3) SI Joint fusion adjunct to a spine fusion construct. The company derives the majority of its revenue from sales of The Catamaran System to a limited number of clinicians.